SCHEMBL22064391

SCHEMBL22064391

N#Cc1ncccc1-c1nn(Cc2ccc(Cl)cc2)c(=O)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.59
▸ NPSR1 Q6W5P4 3/20 0.59
▸ LMNA P02545 2/20 0.59
▸ CYP1A2 P05177 2/20 0.59
▸ CYP3A4 P08684 2/20 0.59
▸ CYP2C9 P11712 2/20 0.59
▸ CYP2C19 P33261 2/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ HRH3 Q9Y5N1 2/20 0.46
▸ PDE4A P27815 2/20 0.44
▸ PDE4B Q07343 2/20 0.44
▸ PDE4C Q08493 2/20 0.44
▸ PDE4D Q08499 2/20 0.44
▸ PDE3B Q13370 2/20 0.44
▸ PDE3A Q14432 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ EP300 Q09472 1/20 0.42
▸ CREBBP Q92793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22064383 0.91 ALDH1A1 (0.48) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064430 0.85 ALDH1A1 (0.65) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064361 0.83 ALDH1A1 (0.62) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064764 0.83 ALDH1A1 (0.62) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064382 0.80 ALDH1A1 (0.47) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064379 0.80 ALDH1A1 (0.47) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064373 0.78 ALDH1A1 (0.68) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL24062560 0.76 ALDH1A1 (0.53) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064901 0.74 ALDH1A1 (0.82) ALDH1A1NPSR1LMNACYP1A2CYP3A4
SCHEMBL22064900 0.74 ALDH1A1 (0.77) ALDH1A1NPSR1LMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666767-B1 PHTHALAZINONE DERIVATIVES, METHOD FOR THEIR PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING THEM, AND THEIR USE SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-12-01 — — EP disclosed
US-11040952-B2 Phthalazinone compound, method for preparation thereof, pharmaceutical composition thereof, and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2021-06-22 — — US disclosed
EP-3666767-A1 PYRIDAZINONE COMPOUND, METHOD FOR PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2020-06-17 — — EP disclosed
US-20200181109-A1 PHTHALAZINONE COMPOUND, METHOD FOR PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181109-A1 PHTHALAZINONE COMPOUND, METHOD FOR PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF POLRMT, POLN, HCCS ALDH1A1 3846/4885NPSR1 3538/4885LMNA 321/4885
US-11040952-B2 Phthalazinone compound, method for preparation thereof, pharmaceutical composition thereof, and use thereof POLRMT, POLN, HCCS ALDH1A1 3846/4885NPSR1 3538/4885LMNA 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback